Clinical Trials Browser

Phase 2 × Prostatic Neoplasms × apatorsen × Clear all

NCT01681433 2022-07-11

OGX-427 in Metastatic Castrate-Resistant Prostate Cancer With Prostate-Specific Antigen Progression While Receiving Abiraterone

Phase 2 Terminated

72 enrolled 14 charts

Prostatic Neoplasms

NCT01120470 2019-02-15

OGX-427 in Castration Resistant Prostate Cancer Patients

Phase 2 Completed

Prostatic Neoplasms